Press release
Peptide Based Cancer Therapeutics Market To Surpass A Valuation of US$ 11,100 Mn Over 2022 || Key Player: AbbVie Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC
Medical institutions across the world are ramping up their efforts towards the development of effective therapeutic drugs for cancer treatment. In addition to this, investors are underpinning the initiatives of healthcare organizations by funding their researches. With the report produced by the World Health Organization (WHO) stating the occurrence of over 8 Mn deaths in 2015 backed by the pervasiveness of cancer, proliferating adoption of advanced peptide based cancer therapeutic is witnessed. A host of these factors have contributed to the growing size of the peptide-based cancer therapeutics market at the global level with an estimated CAGR of over 9% through 2022.
Get Free Sample Report Here:
https://www.factmr.com/connectus/sample?flag=S&rep_id=179
North America enjoys a large concentration of peptide based cancer therapeutic drug manufacturers, which has reflected positively on the growth of this market. Additionally, the advanced healthcare infrastructures have also been a driving factor fostering the growth of this market.
On the basis of drugs, the bortezomib segment is expected to remain highly attractive throughout the assessment period. The segment currently accounts for around 40% revenue share of the global market. Between 2017 and 2022, the segment is expected to reflect a double-digit CAGR to reach a valuation is excess of US$ 4,725 Mn. It expected to grow at US$ 358.4 Mn annually over the course of the forecast period.
Peptide Based Cancer Therapeutics Market: Synopsis of the Report
The primary aim of this market study on peptide-based cancer therapeutics is to lend a holistic view of the market to the stakeholders. The forecast has been done for the period from 2017 to 2022. Here, 2017 is considered as the base year and prediction has been provided for the duration 2018 to 2022. The market evaluation has been done in revenue (US$ Mn).
The report commences with a detailed executive summary, which further provides the scope of the study. An analysis of the year-over-year growth is incorporated in the study, with a view to providing information on the growth patterns of the market. In the succeeding section of the report, macroeconomic and microeconomic factors influencing the market growth has been discussed and included. The report delineates demand drivers, opportunities, threats, restraints and challenging, impacting the market at the global level. A segment-wise analysis is also included in the report, in order to lend a decisive view of the market to the stakeholders.
Browse Full Report with ToC Here:
https://www.factmr.com/report/179/peptide-based-cancer-therapeutics-market
An analysis of the supply chain and average pricing is discussed in the report to understand the dynamics of the peptide-based cancer therapeutics market. Evaluation of the attractiveness of the market has been carried out on the basis of region, drug, and distribution channel.
Outline of Dominant Competitors and Geographies Influencing the Growth of the Peptide-based Cancer Therapeutics Market
The regions analyzed in the report consist of Latin America, North America, Europe, Japan, Asia Pacific except Japan (APEJ), and the Middle East and Africa (MEA). The regions have been analyzed keeping the segments – drug and distribution channel and their revenue share to the global market in mind.
The leading companies profiled in this market study includes Allergan plc, Valeant Pharmaceuticals International, Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Johnson & Johnson, and Abbott, Pfizer Inc. An in-depth company overview, business strategies, market size, and recent developments are discussed in this report. These insights incorporated in the report will aid the drug manufacturers, raw material distributors, and research institutes in devising informed strategies to capture a large market share.
Have Any Query?? Ask Our Industry Expert
https://www.factmr.com/connectus/sample?flag=AE&rep_id=179
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
sales@factmr.com
www.factmr.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Based Cancer Therapeutics Market To Surpass A Valuation of US$ 11,100 Mn Over 2022 || Key Player: AbbVie Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC here
News-ID: 1688016 • Views: …
More Releases from Fact.MR
Insulated Drinkware Market to Hit USD 2.57 Billion by 2033 | YETI, Thermos L.L.C …
The global insulated drinkware market was valued at US$ 1.39 billion in 2023 and is forecasted to expand at a 6.3% CAGR over the next ten years. Worldwide sales of insulated drinkware are projected to reach US$ 2.57 billion by 2033-end.This robust growth is driven by increasing consumer awareness of sustainability, rising participation in outdoor activities, and the growing demand for reusable, eco-friendly products amid bans on single-use plastics.
The market…
Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB L …
Digital Twin Market is valued at USD 5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 34.3%, reaching USD 95 billion by 2033. This explosive growth is driven by the increasing adoption of digital twins across industries to optimize operations, reduce costs, and enhance decision-making through virtual replicas of physical assets. Digital twins integrate IoT, AI, and data analytics to simulate real-world…
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 …
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR). Hemato oncology testing plays a…
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 203 …
Osseointegration Implants Market is poised for robust growth, with its valuation projected to rise from USD 3.17 billion in 2025 to USD 6.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8%. This expansion is driven by the increasing prevalence of orthopedic and dental disorders, such as osteoarthritis, rheumatoid arthritis, and edentulism, which necessitate advanced implant solutions. Osseointegration implants, which fuse directly with bone to provide stable…
More Releases for Peptide
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
